Nantong Guangyuan Chemical: difference between revisions
Diff·revision 34 → 35·23:59, 10 Feb 2025
Difference between revision 34 and revision 35 of Nantong Guangyuan Chemical. 7 lines changed; the page grew by 788 bytes.
| Revision 34 — 22:01, 3 Feb 2025 VerifyFirstVida (talk) label community tally as self-reported 6,634 bytes ±0 | Revision 35 — 23:59, 10 Feb 2025 BlankVialBo (talk) expand §Independent testing record 7,422 bytes +788 | ||
|---|---|---|---|
| 19 | }} | 19 | }} |
| 20 | {{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}} | 20 | {{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}} |
| + | 21 | {{primarysources|date=July 2026|talk=Multiple trading names: which is the title?}} | |
| 21 | 22 | ||
| 22 | '''Nantong Guangyuan Chemical Co., Ltd.''' (trading as '''GGPeps'''; ggpeps.net) is a peptide supplier based in Nantong, Jiangsu, China, trading under several designations including GGPeps and GYC, operating a distributed warehouse network and with a substantial associated third-party testing record.{{r|registry,selfpub}} | 23 | '''Nantong Guangyuan Chemical Co., Ltd.''' (trading as '''GGPeps'''; ggpeps.net) is a peptide supplier based in Nantong, Jiangsu, China, trading under several designations including GGPeps and GYC, operating a distributed warehouse network and with a substantial associated third-party testing record.{{r|registry,selfpub}} |
| ⋮ | ⋮ | ||
| 47 | 48 | ||
| 48 | The catalogue is conventional. The warehouse arrangement, not the range, is what distinguishes the organisation operationally.{{r|reports}} | 49 | The catalogue is conventional. The warehouse arrangement, not the range, is what distinguishes the organisation operationally.{{r|reports}} |
| + | 50 | ||
| + | 51 | == Independent testing record == | |
| + | 52 | The associated report set is among the larger on the wiki, second only to the Wuhan entity.{{r|reports}} Reported [[Area percent purity|area percent]] figures have mostly clustered in the high nineties with a modest tail below. | |
| + | 53 | ||
| + | 54 | == Reception == | |
| + | 55 | The PeptidePedia tally records 1,131 self-reported submissions to July 2026 — the second-largest count in this group. Recurring positive themes are delivery speed from regional stock and catalogue availability; recurring complaints concern the multiple trading names, documentation consistency, and uncertainty about how long material had been in storage.{{r|tally}} Self-selected; reception rather than quality.{{r|tally}} | |
| 49 | 56 | ||
| 50 | == References == | 57 | == References == |